Core Insights - Polyrizon Ltd. has appointed Asaf Azulay as VP of Regulatory Affairs and Quality Assurance, reflecting the company's commitment to high industry standards as it advances its innovative pipeline [1][4] - Azulay brings over 20 years of experience in the medical devices industry, which will be crucial for ensuring compliance with international regulatory standards [2] - The role of RA/QA leader is increasingly important as regulations tighten, focusing on patient safety and preventing roadblocks to innovation [3] Company Overview - Polyrizon is a development stage biotech company specializing in innovative intranasal hydrogels, designed to create a barrier against viruses and allergens in the nasal cavity [5] - The company's proprietary technology, Capture and Contain (C&C), functions as a "biological mask" and is delivered via nasal sprays, with ongoing development to enhance bioadhesion and drug retention [5] - Polyrizon is also developing an earlier-stage technology, Trap and Target (T&T), focused on the nasal delivery of active pharmaceutical ingredients [5]
Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance